thefirst is that we changed the perspective of the focus on the right companies to disseminate information to now furcusing on the right of patients to have information and with the company's obligation to public
The first is that we tried to change the perspective of the legislation from a focus on the right of pharmaceutical companies to disseminate information to now focusing on the right of patients to have access to information and, with that, the companies' obligation to publish and make available this information.
The first is that we change the perspective of the focus on the right companies to disseminate information to now focusing on the right of patients to have information and, with the companies' obligation to publish and make available information.